Solvay strengthens its competitiveness in Germany through portfolio realignment and investments

Summary by AI BETAClose X

Solvay is realigning its German operations, positioning its Bad Wimpfen site as a global hub for Nocolok production, research, and application. This involves discontinuing Trifluoroacetic Acid (TFA)-related organics by early 2026 and some inorganics, including Hydrogen Fluoride, by the end of 2026, resulting in a net reduction of approximately 100 positions in Bad Wimpfen. The Garbsen site will cease operations by 2028, impacting around 40 positions. Solvay will invest approximately €25 million, primarily in 2026, in restructuring expenses and strategic investments, including a state-of-the-art Nocolok Paste & Paint facility and the relocation of the Nocolok Tech Center to Bad Wimpfen.

Disclaimer*

Companies

Solvay SA (0NZR)
UK 100

Latest directors dealings